Orbis Allan Gray’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-2,608
| Closed | -$201K | – | 75 |
|
|
2022
Q2 | $201K | Hold |
2,608
| – | – | ﹤0.01% | 72 |
|
|
2022
Q1 | $190K | Buy |
+2,608
| New | +$190K | ﹤0.01% | 72 |
|
|
2020
Q2 | – | Sell |
-2,608
| Closed | -$145K | – | 63 |
|
|
2020
Q1 | $145K | Sell |
2,608
-5,479,261
| -100% | -$305M | ﹤0.01% | 62 |
|
|
2019
Q4 | $352M | Buy |
+5,481,869
| New | +$352M | 2.46% | 13 |
|
|
2019
Q2 | – | Sell |
-656,994
| Closed | -$31.3M | – | 58 |
|
|
2019
Q1 | $31.3M | Sell |
656,994
-3,458,095
| -84% | -$165M | 0.21% | 33 |
|
|
2018
Q4 | $214M | Buy |
4,115,089
+998,296
| +32% | +$51.9M | 1.54% | 16 |
|
|
2018
Q3 | $193M | Buy |
3,116,793
+158,735
| +5% | +$9.85M | 1.11% | 23 |
|
|
2018
Q2 | $164M | Sell |
2,958,058
-4,585,538
| -61% | -$254M | 0.91% | 24 |
|
|
2018
Q1 | $477M | Buy |
7,543,596
+641,926
| +9% | +$40.6M | 2.73% | 15 |
|
|
2017
Q4 | $423M | Buy |
6,901,670
+1,635,666
| +31% | +$100M | 2.48% | 16 |
|
|
2017
Q3 | $336M | Buy |
+5,266,004
| New | +$336M | 2.07% | 19 |
|